These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9206571)

  • 1. [The pharmacokinetics of the dipeptide analog of piracetam with nootropic activity GVS-111 and of its basic metabolites].
    Boĭko SS; Zherdev VP; Dvorianinov AA; Gudasheva TA; Ostrovskaia RU; Voronina TA; Rozantsev GG; Seredenin SB
    Eksp Klin Farmakol; 1997; 60(2):53-5. PubMed ID: 9206571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-L-prolylglycine.
    Gudasheva TA; Boyko SS; Ostrovskaya RU; Voronina TA; Akparov VK; Trofimov SS; Rozantsev GG; Skoldinov AP; Zherdev VP; Seredenin SB
    Eur J Drug Metab Pharmacokinet; 1997; 22(3):245-52. PubMed ID: 9358206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of the HPLC method for the quantitative determination of a peptide analog of piracetam with nootropic activity and its main metabolites].
    Boĭko SS; Zherdev VP; Gudasheva TA; Vasilevich NI; Ostrovskaia RU; Voronina TA; Rozantsev GG
    Eksp Klin Farmakol; 1996; 59(2):38-40. PubMed ID: 8974563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the novel dipeptide nootropic agent noopept and its metabolite cyclo-L-prolylglycine on the transcallosal evoked potential in the rat brain].
    Molodavkin GM; Borlikova GG; Voronina TA; Gudasheva TA; Ostrovskaia RU; Tushmalova NA; Seredenin SB
    Eksp Klin Farmakol; 2002; 65(2):3-5. PubMed ID: 12109288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Design of the novel dipeptide neuropsychotropic drug preparations].
    Gudasheva TA; Skoldinov AP
    Eksp Klin Farmakol; 2003; 66(2):15-9. PubMed ID: 12962042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of new nootropic acylprolyldipeptide and its penetration across the blood-brain barrier after oral administration.
    Boiko SS; Ostrovskaya RU; Zherdev VP; Korotkov SA; Gudasheva TA; Voronina TA; Seredenin SB
    Bull Exp Biol Med; 2000 Apr; 129(4):359-61. PubMed ID: 10977920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proline-containing dipeptide GVS-111 retains nootropic activity after oral administration.
    Ostrovskaya RU; Mirsoev TK; Romanova GA; Gudasheva TA; Kravchenko EV; Trofimov CC; Voronina TA; Seredenin SB
    Bull Exp Biol Med; 2001 Oct; 132(4):959-62. PubMed ID: 11782792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of the new nootropic dipeptide GVS-111 in different functional disorders of the escape reaction].
    Inozemtsev AN; Trofimov SS; Borlikova GG; Firova FA; Pragina LL; Gudasheva TA; Ostrovskaia RU; Tushmalova NA; Voronina TA
    Eksp Klin Farmakol; 1998; 61(3):10-2. PubMed ID: 9690067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dipeptide nootropic agent GVS-111 prevents accumulation of the lipid peroxidation products during immobilization].
    Lysenko AV; Uskova NI; Ostrovskaia RU; Gudasheva TA; Voronina TA
    Eksp Klin Farmakol; 1997; 60(5):15-8. PubMed ID: 9483398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of functional state of neuronal mitochondria of cerebral cortex in mechanisms of nootropic activity of neuroprotectors in rats with alloxan hyperglycemia].
    Zhiliuk VI; Mamchur VI; Pavlov SV
    Eksp Klin Farmakol; 2015; 78(2):10-4. PubMed ID: 25898541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective properties of nootropic dipeptide GVS-111 in in vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress.
    Andreeva NA; Stel'mashuk EV; Isaev NK; Ostrovskaya RU; Gudasheva TA; Viktorov IV
    Bull Exp Biol Med; 2000 Oct; 130(10):969-72. PubMed ID: 11177296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance characteristics of a new levetiracetam immunoassay and method comparison with a high-performance liquid chromatography method.
    Reineks EZ; Lawson SE; Lembright KE; Wang S
    Ther Drug Monit; 2011 Feb; 33(1):124-7. PubMed ID: 21157399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic and megabore gas-liquid chromatographic determination of levetiracetam (ucb L059) in human serum after solid-phase extraction.
    Vermeij TA; Edelbroek PM
    J Chromatogr B Biomed Appl; 1994 Dec; 662(1):134-9. PubMed ID: 7894687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multicomponent antithrombotic effect of the neuroprotective prolyl dipeptide GVS-111 and its major metabolite cyclo-L-prolylglycine].
    Ostrovskaia RU; Liapina LA; Pastorova VE; Mirzoev TKh; Gudasheva TA; Seredenin SB; Ashmarin IP
    Eksp Klin Farmakol; 2002; 65(2):34-7. PubMed ID: 12109290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification in the rat brain of cyclo-prolylglycine, a novel endogenous peptide with nootropic activity].
    Gudasheva TA; Boĭko SS; Akparov VKh; Ostrovskaia RU; Rozantsev GG; Voronina TA; Zherdev VP; Seredenin SB
    Dokl Akad Nauk; 1996 Oct; 350(6):834-6. PubMed ID: 8998456
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interspecies differences of noopept pharmacokinetics].
    Boĭko SS; Korotkov SA; Zherdev VP; Gudasheva TA; Ostrovskaia RU; Voronina TA
    Eksp Klin Farmakol; 2004; 67(1):40-3. PubMed ID: 15079908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel endogenous memory facilitating cyclic dipeptide cyclo-prolylglycine in rat brain.
    Gudasheva TA; Boyko SS; Akparov VKh; Ostrovskaya RU; Skoldinov SP; Rozantsev GG; Voronina TA; Zherdev VP; Seredenin SB
    FEBS Lett; 1996 Aug; 391(1-2):149-52. PubMed ID: 8706904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of the nootropic drugs].
    Boĭko SS; Vitskova GIu; Zherdev VP
    Eksp Klin Farmakol; 1997; 60(6):62-70. PubMed ID: 9460604
    [No Abstract]   [Full Text] [Related]  

  • 19. [Strategy for the development of dipeptide drugs].
    Gudasheva TA
    Vestn Ross Akad Med Nauk; 2011; (7):8-16. PubMed ID: 21899085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of noopept and its active metabolite cycloprolyl glycine in rats].
    Boyko SS; Zherdev VP; Shevchenko RV
    Biomed Khim; 2018 Sep; 64(5):455-458. PubMed ID: 30378564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.